PUMA BIOTECHNOLOGY, INC. (25) | Uncategorized (5)
Recent Contracts
-
Open Market Sale AgreementSM, dated November 4, 2021, by and between Puma Biotechnology, Inc. and Jefferies LLC
(Filed With SEC on November 4, 2021)
-
Letter Agreement, dated February 13, 2020, by and between the Company and Jeff J. Ludwig
(Filed With SEC on March 1, 2021)
-
Pfizer Letter Agreement dated June 8, 2020, by and between the Company and Pfizer Inc
(Filed With SEC on August 6, 2020)
-
Description of the Company's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on February 28, 2020)
-
Side Letter Agreement, dated November 19, 2018, between the Company and CANbridge Biomed Limited (as successor in interest to CANbridgepharma Limited)
(Filed With SEC on March 1, 2019)